Significant Ownership of MAVERICK CAPITAL LTD

Notable people
Lee Ainslie
Signature - Title
By Maverick Capital Management, LLC - its Manager
Location
Dallas, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by MAVERICK CAPITAL LTD.

Follow Filing Activity

Follow MAVERICK CAPITAL LTD and return when a new Schedule 13D/G filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Significant Ownership of MAVERICK CAPITAL LTD

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Infleqtion, Inc. Common Stock, $0.0001 par value per share 9.2% 19,976,664 Maverick Capital Management, LLC 13 Feb 2026
IVVD Invivyd, Inc. Common Stock, $0.0001 par value per share 6.7% $47,806,701 +$22,029,323 18,970,913 +85% Maverick Capital, Ltd. 31 Dec 2025
WVE Wave Life Sciences Ltd. $0 Par Value Ordinary Shares 5.4% $56,093,833 8,261,242 Maverick Capital, Ltd. 31 Dec 2024
VRNA Verona Pharma Plc Ordinary Shares, nominal value 0.05 GBP per share 3.8% $1,638,341,259 25,028,128 Maverick Capital, Ltd. 31 Dec 2024
BTU Peabody Energy Corporation Common Stock, par value $0.01 per share 3.3% $137,470,447 -$138,250,112 4,067,173 -50% Maverick Capital, Ltd. 31 Dec 2025
GUTS Fractyl Health, Inc. Common Stock, $0.00001 par value per share 3.1% $6,755,102 4,248,492 Maverick Capital, Ltd. 30 Sep 2025
RCKT Rocket Pharmaceuticals, Inc. Common stock, $0.01 par value per share 2.3% $9,549,818 -$22,232,671 2,513,110 -70% Maverick Capital, Ltd. 31 Dec 2025
CRIS Curis, Inc. Common Stock, par value $0.01 per share 0.4% $82,260 -$1,048,833 49,554 -93% Maverick Capital, Ltd. 30 Sep 2025

Schedules 13D/G Reported by MAVERICK CAPITAL LTD:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.